Neoplasia/BPH

	Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy. World J Clin Oncol Meng LL, Di YP, Ma L, Qu BL. PMID: 41480171 [PubMed]
	Microfluidics and molecular diagnostics in renal cell carcinoma: advances, challenges, and future directions. Front Oncol Abu-Dawas SB, Alwadi AY, Farahat YH, Abu-Dawas RB, Quraiba LN, Abu-Omar RA, AlKattan K, Khan MI, Yaqinuddin A. PMID: 41479787 [PubMed]
	Deep learning-based dose prediction for prostate cancer with empty bladder protocol: a framework for efficient and personalized radiotherapy planning. Front Oncol Choi B, Shrestha DK, Attia A, Stish BJ, Leenstra J, Rwigema JC, Ma J, Lee SU, Jeong JH, Kim J, Kim J, Beltran C, Park JC. PMID: 41479786 [PubMed]
	Preoperative loco-regional assessment of prostate carcinoma using multi-parametric MRI and prostate-specific membrane antigen PET-computed tomography: correlation with histopathology. Nucl Med Commun Lal H, Malik D, Singh A, Prasad R, Sureka S, Nazar AH, Agarwal V, Kishun J, Yadav P, Jowel P. PMID: 41479341 [PubMed - as supplied by publisher]
	Relapsed rhabdoid tumours and other non-nephroblastoma childhood and adolescent kidney tumours: perspectives from the HARMONICA collaboration. Nat Rev Urol Ortiz MV, Wens FSPL, Hong AL, Quarello P, Verschuur AC, Tracy ET, Daw NC, Dome JS, Walz AL, Sprokkerieft J, Tytgat GAM, Kentsis A, Libes-Bander J, Schoettler PJ, Perotti D, Drost J, Venkatramani R, Geller JI, van den Heuvel-Eibrink MM. PMID: 41478859 [PubMed - as supplied by publisher]
	Comparison of Results from the BARCODE1 Study and Contemporary Prostate Cancer Screening Trials. Eur Urol Oncol Sud A, McNeill A, Vickers AJ. PMID: 41478782 [PubMed - as supplied by publisher]
	Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC Recurrence. Eur Urol Oncol Soria F, Liedberg F, Stahl E, Dominguez-Escrig JL, Moschini M, Pradere B, D'Andrea D, Teoh JY, Capoun O, Soukup V, Rai BP, Birtle A, Compérat EM, Mariappan P, van Rhijn BWG, Baard J, Seisen T, Xylinas EN, Shariat SF, Gontero P, Masson-Lecomte A. PMID: 41478781 [PubMed - as supplied by publisher]
	Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-GuÃ©rin (BCG) in BCG-naÃ¯ve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials. Eur Urol Scilipoti P, Zaurito P, Longoni M, Colecchia M, Montorsi F, Salonia A, Mercinelli C, Maiorano B, Necchi A, Briganti A, Moschini M. PMID: 41478774 [PubMed - as supplied by publisher]
	Multiplexed 3D-rGO/AuNP electrochemical aptasensor for ultrasensitive detection of urinary PSMA in prostate cancer diagnosis. Talanta Amin-Sadrabadi E, Koudehi MF, Behroozi J, Zibaseresht R, Chamanara M, Khomartash MS, Gorgani-Firuzjaee S, Fasihi Dastjerdi H, Heidari MF, Omidfar K. PMID: 41478044 [PubMed - as supplied by publisher]
	Incorporating physicians' contouring style into auto-segmentation of clinical target volume for post-operative prostate cancer radiotherapy using a language encoder. Mach Learn Health Zhao H, Liao CY, Yang D, Jiang S, Nguyen D. PMID: 41477361 [PubMed]
	The impact of diet and gut microbiota on development, treatment, and prognosis in prostate cancer. Front Nutr Liu G, Yang F, Song W, Hou R. PMID: 41477313 [PubMed]
	Identification and Validation of a Prognostic Signature Based on mRNAs Associated with Low-Density Lipoprotein Receptor-Related Proteins for Kidney Renal Clear Cell Carcinoma: Insights Into Tumor Immune Microenvironment, Mutation Patterns, and Personalized Treatment Strategies. Int J Gen Med Xie L, Zhou Y, Hu Z, Zhang S, Fan M, Huang X, Zhang W, Liu Z. PMID: 41477155 [PubMed]
	Machine learning-derived cellular senescence index for predicting prognosis and drug sensitivity in patients with renal cell carcinoma. Front Immunol Meng L, Zhang H, Qiu Y, Zhu X, Ji X, Wang B, Zhang G, Xue Y, Wang C. PMID: 41476960 [PubMed - indexed for MEDLINE]
	A Small Indole Derivative Isolated From Caper (Capparis ovata) as an Inducer of P53-Mediated Apoptosis in Prostate Cancer: Comprehensive In Vitro and In Silico Studies. J Biochem Mol Toxicol Acar ÖÖ, Gazio, Oruç H, Kale E, , Topçu G, . PMID: 41476392 [PubMed - indexed for MEDLINE]
	Combined use of Indocyanine Green, intraoperative ultrasound, and three-dimensional model of kidney for nephron-sparing surgery in complex renal masses. J Cancer Res Ther Gupta P, Nayyar R, Kumar S. PMID: 41474565 [PubMed - indexed for MEDLINE]
	AI-driven precision in prostate brachytherapy: A systematic review of 70 studies. J Cancer Res Ther Pareek V, Dube S, Patil N, Johnny C, Mutua F, Bashir B. PMID: 41474559 [PubMed - indexed for MEDLINE]
	Identification of prognostic genes associated with mitochondria and macrophage polarization in prostate adenocarcinoma based on transcriptome and Mendelian randomization analysis. Discov Oncol Heng L, Bian H, Zhao C, Wei Z, Cao J, Wang G. PMID: 41474538 [PubMed - as supplied by publisher]
	Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations. World J Urol Wang Y, Zhao W, Wang R, Qi M, Zhang L, Xi D, Wang M, Yan R, Lei J. PMID: 41474500 [PubMed - indexed for MEDLINE]
	Nightshift work and risk of breast and prostate cancer: a systematic review and meta-analysis, 2012-2023. An Sist Sanit Navar Soler-Saña M, Puiggené-Vallverdú M, Godoy P. PMID: 41473964 [PubMed - indexed for MEDLINE]
	A Single-Center, Retrospective, Real-World, Observational Clinical Study to Evaluate the Safety and Efficacy of Abiraterone (Abiratred) in Patients with Metastatic Prostate Cancer. South Asian J Cancer Danchaivijitr P, Archwamety A, Wongkraisri C. PMID: 41473368 [PubMed]

Articles 1 - 20 / 184367

Page 1 of 9219



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy